Top Markets
#1 Siren Siren +35.33%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.89%
#3 PulseChain PulseChain +18.03%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.88%
#5 TROLL TROLL +17.29%
#6 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +17.03%
#7 KUB Coin KUB Coin +16.85%
#8 The Grays Currency The Grays Currency +16.55%
#9 OpenEden OpenEden +16.30%
#10 Wrapped Pulse Wrapped Pulse +15.57%
Coin of the day
Siren Siren
設定
言語
日本
通貨
USD
テーマ
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
株式のランク #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
株価
$0.4018
時価総額
$14.12M
変化（1日）
-3.20%
変化（1年）
-88.15%
国
US
取引 Skye Bioscience, Inc. (SKYE)

カテゴリー

Healthcare
Skye Bioscience, Inc.（SKYE）のEPS
2026 時点のEPS TTM: 0
Skye Bioscience, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Skye Bioscience, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE